Pancreatic Gastrin-Producing Neuroendocrine Tumor

Pancreatic Gastrin-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01229943	Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery	completed	Phase 2	150	National Cancer Institute (NCI)NIH	2	Aug 4, 2022	clinicaltrials
NCT03147768	Laser Tissue Welding - Distal Pancreatectomy Sealing Study(LTW)	completed	Phase 1	11	Laser Tissue Welding, Inc.INDUSTRY	1	Apr 6, 2022	clinicaltrials
NCT01465659	Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery	completed	Phase 1 / Phase 2	29	Northwestern UniversityOTHER	1	Aug 5, 2021	clinicaltrials
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	completed

Data updated 22 days agoSource updated Aug 4, 2022source: clinicaltrials